Table 5 Patients' recognition of risk factor treatment.
Treatment | Number of patients who reported treatment n = 182 (%) | Number of those who marked the treatment as intended for stroke/TIA prevention n = first column (%) |
|---|---|---|
Anticoagulants (warfarin) | 32 (17.6) | 18 (56.3) |
Platelet aggregation inhibitors | 114 (62.4) | 55 (48.2) |
Antihypertensive agents | 120 (66.0) | 43 (35.8) |
Antilipemic agents | 73 (40.1) | 26 (35.6) |
Hypoglycemic agents | 21 (11.5) | 3 (14.3) |